Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2017-09-30
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Cheek Acupuncture Therapy for Pain Control After Cesarean Delivery
NCT06795594
Auriculotherapy - Pain Management of Aspiration Abortion
NCT03896022
Influence of Acupuncture in the Postpartum Blood Loss
NCT02539121
Acupuncture for the Prevention of Postdates Pregnancy
NCT00312585
Acupoint Stimulation Improves Sleep on the Plateau
NCT05396729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.
Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.
* To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
* Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.
Population:
The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.
Objectives:
* Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
* Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .
Study design:
* Study Type: Multicentre, Interventional, randomized, 2 parallel groups
* Endpoint Classification: Efficacy Study
* Intervention Model: Parallel Assignment
* Masking: Single blind (patient blinded to intervention)
* Primary Purpose: Treatment
* One acupuncture session weekly for 4 consecutive weeks
Visits:
* Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
* Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
* Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
* End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
5 bilateral acupoints or placebo acupoints,
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
Acupuncture needles
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
Acupuncture needles
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture needles
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy
* Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
* Insomnia Severity Index ≥ 10
* Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
* Patient understanding the study
* Informed consent signed
* Social insurance available at inclusion and until the end of pregnancy
Exclusion Criteria
* Small fetus for gestational age
* Pre-eclampsia
* Insomnia starting before pregnancy
* Use of psychotropic drugs before pregnancy
* Use of recreational drugs during pregnancy
* Known psychiatric disorder
* Anticoagulant therapy
* Patient reporting insomnia results from chronic or acute pain
* Obstructive sleep apnea (OSA) requiring treatment
* Patient under antidepressant therapy
* Patient under legal guardianship or deprived of freedom
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphanie Nicolian, Midewife
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P150951
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.